GO:0097050 type B pancreatic cell apoptotic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097050 describes the apoptotic process occurring specifically in type B pancreatic cells (insulin-secreting beta cells) located toward the center of the islets of Langerhans.
• Beta-cell apoptosis is a central mechanism of beta-cell loss in both type 1 and type 2 diabetes, contributing to insulin deficiency and hyperglycemia.
• Multiple stressors trigger beta-cell apoptosis, including islet amyloid polypeptide (IAPP) aggregation, mitochondrial dysfunction, inflammatory cytokines, and glucolipotoxicity.
• Key molecular players include Bcl-2 family proteins, caspases, COX6A2, Klotho, FXR, and adenylosuccinate metabolism.
• Loss of beta-cell identity and dedifferentiation may precede or accompany apoptosis, and these processes are not always irreversible.
• Research models for GO:0097050 include CRISPR knockout/knock-in of candidate genes, overexpression studies, and exosome-based interventions.
Description
Type B pancreatic cells, commonly known as beta cells, are specialized endocrine cells located toward the center of the islets of Langerhans that produce and secrete insulin. The Gene Ontology term GO:0097050, type B pancreatic cell apoptotic process, refers to any apoptotic process occurring in these cells. Apoptosis is a programmed form of cell death that, when inappropriately activated in beta cells, leads to progressive loss of insulin-secreting capacity and contributes to the pathogenesis of diabetes mellitus. Understanding the molecular mechanisms that govern beta-cell apoptosis is therefore critical for developing therapeutic strategies to preserve beta-cell mass and function. Research into GO:0097050 has revealed that beta-cell apoptosis is triggered by diverse stressors, including proinflammatory cytokines, glucolipotoxicity, endoplasmic reticulum stress, mitochondrial dysfunction, and islet amyloid polypeptide (IAPP) aggregation. These stressors activate intrinsic and extrinsic apoptotic pathways, leading to caspase activation, DNA fragmentation, and cell death. The term is distinct from other forms of cell death such as necrosis or autophagy, although crosstalk between these processes exists. Studying GO:0097050 is essential for understanding diabetes pathogenesis and for identifying therapeutic targets. For example, Klotho, an antiaging gene, has been shown to attenuate pancreatic beta-cell apoptosis in type 1 diabetes. Similarly, modulation of mitochondrial proteins such as COX6A2 and metabolic intermediates like adenylosuccinate can influence beta-cell survival. This article provides a comprehensive overview of the definition, mechanisms, key genes, research models, and methods relevant to GO:0097050.
type B pancreatic cell apoptotic process At A Glance
| GO ID | GO:0097050 |
|---|---|
| GO term | type B pancreatic cell apoptotic process |
| Ontology | biological_process |
| Synonym | pancreatic B cell apoptosis; pancreatic beta cell apoptosis; type B pancreatic cell apoptosis |
| Major function | Programmed cell death of insulin-secreting beta cells in the islets of Langerhans |
| Definition | Any apoptotic process in a type B pancreatic cell, a cell located towards center of the islets of Langerhans that secretes insulin |
| Related cell type | Type B pancreatic cell (beta cell) |
| Associated diseases | Type 1 diabetes, type 2 diabetes, and other forms of diabetes mellitus |
| Key pathways | Intrinsic (mitochondrial) apoptosis, extrinsic (death receptor) apoptosis, ER stress-induced apoptosis |
What Is GO:0097050?
GO:0097050, type B pancreatic cell apoptotic process, is defined by the Gene Ontology as any apoptotic process in a type B pancreatic cell, a cell located towards the center of the islets of Langerhans that secretes insulin. In simpler terms, it is the programmed self-destruction of insulin-producing beta cells. This process is a specific biological process that occurs in a particular cell type, distinguishing it from general apoptosis (GO:0006915) and from apoptosis in other pancreatic cell types such as alpha or delta cells.
Why Is type B pancreatic cell apoptotic process Important in Cell Biology?
GO:0097050 is critically important because beta-cell apoptosis is a hallmark of diabetes mellitus, a global health burden. In type 1 diabetes, autoimmune-mediated destruction of beta cells involves apoptosis, while in type 2 diabetes, chronic metabolic stress, inflammation, and amyloid deposition contribute to progressive beta-cell loss. Understanding the molecular regulation of this process can reveal therapeutic targets to preserve beta-cell mass, improve insulin secretion, and potentially reverse or delay diabetes onset. Furthermore, the term provides a standardized framework for annotating gene functions and experimental results related to beta-cell death, facilitating comparative and integrative research across studies.
• Beta-cell apoptosis is a primary mechanism of beta-cell loss in type 1 diabetes, leading to absolute insulin deficiency.
• In type 2 diabetes, beta-cell apoptosis contributes to progressive beta-cell failure and hyperglycemia.
• Islet amyloid polypeptide (IAPP) aggregation is a potent trigger of beta-cell apoptosis in type 2 diabetes.
• Mitochondrial dysfunction, including altered COX6A2 expression, promotes beta-cell apoptosis in diabetes.
• Anti-apoptotic factors such as Klotho can protect beta cells from apoptosis in type 1 diabetes.
• Mesenchymal stem cell-derived exosomes can alleviate beta-cell destruction and apoptosis in type 2 diabetes models.
• Loss of beta-cell identity and dedifferentiation may precede apoptosis and represent reversible states.
• Inflammatory cytokines and candidate genes for type 1 diabetes modulate islet inflammation and beta-cell apoptosis.
• Adenylosuccinate metabolism is linked to imeglimin-induced anti-apoptotic effects in beta cells.
• Understanding beta-cell apoptosis is essential for developing therapies to preserve beta-cell mass and function.
What Happens During type B pancreatic cell apoptotic process?
Initiation by Stressors
In simple terms: Beta cells receive a death signal when they are stressed.
Beta-cell apoptosis can be initiated by a variety of stressors, including proinflammatory cytokines (e.g., IL-1beta, TNF-alpha, IFN-gamma), glucolipotoxicity, endoplasmic reticulum (ER) stress, oxidative stress, and islet amyloid polypeptide (IAPP) aggregation. These stressors activate intracellular signaling pathways that converge on the mitochondria or death receptors. For example, IAPP cytotoxicity involves membrane disruption and activation of apoptotic cascades. In type 1 diabetes, candidate genes such as those in the HLA region modulate islet inflammation and beta-cell apoptosis.
Mitochondrial Outer Membrane Permeabilization
In simple terms: The mitochondria decide whether the cell should die.
The intrinsic apoptotic pathway is regulated by Bcl-2 family proteins. Pro-apoptotic members such as Bax and Bak undergo activation and oligomerization, leading to mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and other pro-apoptotic factors from the intermembrane space into the cytosol. Mitochondrial dysfunction, including altered expression of cytochrome c oxidase subunit COX6A2, has been implicated in beta-cell apoptosis in type 2 diabetes. The FXR-regulated COX6A2 triggers mitochondrial apoptosis of pancreatic beta cells.
Caspase Activation and Apoptosome Formation
In simple terms: A chain reaction of enzymes dismantles the cell.
Once cytochrome c is released, it binds to Apaf-1 and procaspase-9 to form the apoptosome, which activates caspase-9. Caspase-9 then cleaves and activates executioner caspases-3, -6, and -7. These executioner caspases cleave numerous cellular substrates, leading to DNA fragmentation, cytoskeletal disruption, and formation of apoptotic bodies. In beta cells, caspase activation is a hallmark of apoptosis and can be detected by specific assays.
Extrinsic Pathway and Death Receptors
In simple terms: External signals can also tell the cell to die.
The extrinsic apoptotic pathway is triggered by ligands such as FasL and TNF-related apoptosis-inducing ligand (TRAIL) binding to death receptors (Fas, DR4, DR5) on the beta-cell surface. This leads to recruitment of FADD and procaspase-8, forming the death-inducing signaling complex (DISC). Caspase-8 activation can directly activate executioner caspases or amplify the intrinsic pathway via Bid cleavage. In type 1 diabetes, cytokine-mediated beta-cell apoptosis often involves both extrinsic and intrinsic pathways.
Phagocytosis and Clearance
In simple terms: Dead cells are cleaned up by immune cells.
After apoptosis, beta-cell remnants are rapidly phagocytosed by macrophages or dendritic cells without inducing inflammation, a process known as efferocytosis. However, in diabetes, impaired clearance may lead to secondary necrosis and exacerbation of inflammation. This step is important for understanding the transition from apoptosis to autoimmunity in type 1 diabetes.
Key Genes Involved in GO:0097050 type B pancreatic cell apoptotic process
The following genes and proteins have been experimentally implicated in the regulation or execution of type B pancreatic cell apoptotic process (GO:0097050).
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic Bcl-2 family protein | Overexpression protects beta cells from apoptosis; target for anti-apoptotic therapy |
| BAX | Pro-apoptotic Bcl-2 family protein | Mediates mitochondrial outer membrane permeabilization; knockout reduces apoptosis |
| BAK1 | Pro-apoptotic Bcl-2 family protein | Cooperates with Bax in MOMP; double knockout blocks intrinsic apoptosis |
| CASP3 | Executioner caspase | Final execution of apoptosis; activity assays measure beta-cell death |
| CASP8 | Initiator caspase in extrinsic pathway | Mediates death receptor-induced apoptosis; knockout affects cytokine-induced death |
| CASP9 | Initiator caspase in intrinsic pathway | Apoptosome component; knockout blocks mitochondrial apoptosis |
| COX6A2 | Cytochrome c oxidase subunit | FXR-regulated; triggers mitochondrial apoptosis in type 2 diabetes |
| FXR (NR1H4) | Nuclear receptor transcription factor | Regulates COX6A2 and beta-cell apoptosis; target for diabetes therapy |
| KLOTHO | Antiaging protein | Attenuates beta-cell apoptosis in type 1 diabetes; overexpression protective |
| IAPP | Islet amyloid polypeptide | Aggregates to form toxic oligomers that induce beta-cell apoptosis |
| IL1B | Proinflammatory cytokine | Triggers beta-cell apoptosis via NF-kB and MAPK pathways |
| TNF | Proinflammatory cytokine | Induces apoptosis through TNFR1 and extrinsic pathway |
| IFNG | Proinflammatory cytokine | Synergizes with IL-1beta to induce beta-cell apoptosis |
| FAS | Death receptor | Mediates extrinsic apoptosis in beta cells |
| BID | BH3-only protein | Links extrinsic to intrinsic apoptosis; cleavage by caspase-8 |
| APAF1 | Apoptosome component | Required for caspase-9 activation; knockout blocks intrinsic apoptosis |
| AKT1 | Survival kinase | Phosphorylates Bad and caspase-9 to inhibit apoptosis; overexpression protective |
| TP53 | Tumor suppressor | Can induce apoptosis under severe stress; role in beta cells context-dependent |
How Is type B pancreatic cell apoptotic process Regulated?
The apoptotic process in type B pancreatic cells is tightly regulated by a balance between pro-apoptotic and anti-apoptotic signals. Key regulatory mechanisms include the Bcl-2 family protein interactions, which determine mitochondrial outer membrane permeabilization. The PI3K/Akt signaling pathway promotes survival by phosphorylating and inactivating pro-apoptotic proteins such as Bad and caspase-9. Inflammatory cytokines activate NF-kB and MAPK pathways, which can either promote survival or apoptosis depending on context. Metabolic regulators such as FXR modulate mitochondrial function through COX6A2, influencing apoptosis in type 2 diabetes. Additionally, adenylosuccinate metabolism has been linked to imeglimin-induced anti-apoptotic effects in beta cells. Klotho, an antiaging gene, attenuates beta-cell apoptosis in type 1 diabetes, possibly through inhibition of oxidative stress and NF-kB. Loss of beta-cell identity and dedifferentiation may also regulate susceptibility to apoptosis, and these states are not always irreversible.
type B pancreatic cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COX6A2 | Type 2 diabetes; mitochondrial apoptosis | Beta-cell-specific knockout or overexpression in mice; CRISPR KO in INS-1 cells |
| KLOTHO | Type 1 diabetes; protection against apoptosis | Transgenic overexpression in beta cells; CRISPR knock-in of variant |
| IAPP | Type 2 diabetes; islet amyloidosis | Transgenic mice expressing human IAPP; CRISPR knock-in of hIAPP |
| IL1B | Type 1 diabetes; cytokine-induced apoptosis | Knockout mice or CRISPR KO in beta-cell lines; treatment with IL-1beta |
| FXR (NR1H4) | Type 2 diabetes; regulation of COX6A2 | Beta-cell-specific FXR knockout; CRISPR KO in INS-1 cells |
Type 1 Diabetes
In type 1 diabetes, autoimmune destruction of beta cells is mediated by apoptosis induced by proinflammatory cytokines and autoreactive T cells. Candidate genes for type 1 diabetes modulate islet inflammation and beta-cell apoptosis. Klotho, an antiaging gene, has been shown to attenuate pancreatic beta-cell apoptosis in type 1 diabetes, suggesting a protective role. The loss of beta-cell mass leads to absolute insulin deficiency and hyperglycemia.
Type 2 Diabetes
In type 2 diabetes, beta-cell apoptosis contributes to progressive beta-cell failure in the context of insulin resistance and chronic metabolic stress. Islet amyloid polypeptide (IAPP) aggregation is a hallmark of type 2 diabetes and induces beta-cell apoptosis through membrane disruption and oxidative stress. Mitochondrial dysfunction, including FXR-regulated COX6A2 expression, triggers mitochondrial apoptosis of pancreatic beta cells. Mesenchymal stem cell-derived exosomes can alleviate type 2 diabetes by reversing peripheral insulin resistance and relieving beta-cell destruction, including apoptosis.
Monogenic Diabetes and Dedifferentiation
Loss of beta-cell identity and dedifferentiation may contribute to beta-cell dysfunction and apoptosis in various forms of diabetes. These processes are not always irreversible, suggesting potential for therapeutic restoration of beta-cell function. Understanding the interplay between dedifferentiation and apoptosis is an active area of research.
From type B pancreatic cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate beta-cell apoptosis? | CRISPR knockout of gene X in beta-cell lines (INS-1, MIN6) or primary islets |
| Does a point mutation in gene Y affect apoptosis? | CRISPR point mutation knock-in in beta-cell lines or iPSC-derived beta cells |
| Does overexpression of gene Z protect against apoptosis? | Lentiviral or CRISPR knock-in overexpression in beta cells |
| What is the role of a candidate gene in vivo? | Beta-cell-specific conditional knockout or transgenic mice |
| Can a drug target reduce beta-cell apoptosis? | High-throughput screening with CRISPR libraries in beta-cell lines |
| Does a non-coding variant affect apoptosis? | CRISPR interference (CRISPRi) or activation (CRISPRa) at regulatory regions |
How to Study the type B pancreatic cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI flow cytometry | Phosphatidylserine externalization and membrane integrity | Quantification of early and late apoptosis in beta-cell lines |
| TUNEL assay | DNA fragmentation | Detection of apoptotic beta cells in tissue sections or cultured cells |
| Caspase-3/7 activity assay | Executioner caspase activity | Measurement of apoptosis induction or inhibition |
| JC-1 staining | Mitochondrial membrane potential | Assessment of mitochondrial outer membrane permeabilization |
| Seahorse assay | Oxygen consumption rate and glycolysis | Evaluation of mitochondrial function in beta cells |
| RNA-seq | Global gene expression changes | Identification of apoptotic pathways and candidate genes |
| CRISPR knockout screen | Gene essentiality for apoptosis | Discovery of novel regulators of beta-cell apoptosis |
| Western blot | Protein expression and cleavage | Validation of caspase activation and Bcl-2 family proteins |
Apoptosis Assays
Apoptosis in beta cells can be measured using various methods, including Annexin V/propidium iodide staining followed by flow cytometry, TUNEL staining for DNA fragmentation, and caspase-3/7 activity assays. These methods allow quantification of apoptotic cells in response to stressors or genetic manipulations. For in vivo studies, immunohistochemistry for cleaved caspase-3 or TUNEL can detect beta-cell apoptosis in pancreatic sections.
Mitochondrial Function Analysis
Mitochondrial outer membrane permeabilization and function can be assessed using JC-1 dye for mitochondrial membrane potential, MitoSOX for reactive oxygen species, and Seahorse extracellular flux analysis for oxygen consumption rate. These methods are critical for studying the intrinsic apoptotic pathway in beta cells, especially in the context of COX6A2 and FXR regulation.
Gene Expression and Proteomics
RNA-seq and quantitative RT-PCR can measure expression of pro- and anti-apoptotic genes in beta cells under various conditions. Proteomics, including Western blotting for Bcl-2 family proteins and caspases, provides protein-level validation. Single-cell RNA-seq can reveal heterogeneity in apoptotic susceptibility among beta cells.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate beta-cell apoptosis. These screens use pooled lentiviral libraries and next-generation sequencing to quantify guide RNA enrichment or depletion after induction of apoptosis. Bioinformatics analysis then identifies candidate genes and pathways, which can be validated individually.
How CRISPR Can Be Used to Study GO:0097050 type B pancreatic cell apoptotic process
Knockout
CRISPR knockout is used to delete candidate genes in beta-cell lines or primary islets to determine their role in apoptosis. For example, knocking out COX6A2 or FXR can reveal their contribution to mitochondrial apoptosis in type 2 diabetes. Knockout of anti-apoptotic genes such as BCL2 sensitizes beta cells to apoptosis, while knockout of pro-apoptotic genes like BAX protects them. These models are essential for establishing causality.
Point Mutation
CRISPR point mutation knock-in allows introduction of specific disease-associated variants into the endogenous gene locus. This is particularly useful for studying how single nucleotide polymorphisms (SNPs) in candidate genes affect beta-cell apoptosis. For example, a point mutation in the KLOTHO gene could be introduced to test its effect on apoptosis protection. Point mutations can also be used to create constitutively active or inactive forms of signaling proteins.
Knock-in
CRISPR knock-in can be used to insert reporter genes (e.g., fluorescent proteins) or tags into endogenous loci to monitor apoptosis in real time. For instance, a caspase-3 reporter knock-in beta-cell line can be used for high-throughput screening of anti-apoptotic compounds. Knock-in of human IAPP into mouse beta cells can model islet amyloidosis and apoptosis. Knock-in of tagged proteins also facilitates proteomic and imaging studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase expression of candidate protective genes. Overexpression of KLOTHO or BCL2 in beta cells can protect against apoptosis in models of type 1 diabetes. Overexpression of dominant-negative mutants can also be achieved via knock-in. These models help identify therapeutic targets that enhance beta-cell survival.
How EDITGENE Supports type B pancreatic cell apoptotic process Research
Researchers studying type B pancreatic cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in beta-cell death, and whether its modulation can protect beta cells. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for type B pancreatic cell apoptotic process research.
Frequently Asked Questions About type B pancreatic cell apoptotic process
What is GO:0097050?
GO:0097050 is the Gene Ontology term for type B pancreatic cell apoptotic process, defined as any apoptotic process in a type B pancreatic cell (beta cell) located towards the center of the islets of Langerhans that secretes insulin.
What genes are involved in type B pancreatic cell apoptotic process?
Key genes include BCL2, BAX, BAK1, CASP3, CASP8, CASP9, COX6A2, FXR (NR1H4), KLOTHO, IAPP, IL1B, TNF, IFNG, FAS, BID, APAF1, and AKT1, among others.
How is beta-cell apoptosis measured?
Beta-cell apoptosis is commonly measured by Annexin V/PI flow cytometry, TUNEL staining, caspase-3/7 activity assays, and Western blot for cleaved caspases.
What triggers pancreatic beta cell apoptosis?
Triggers include proinflammatory cytokines (IL-1beta, TNF-alpha, IFN-gamma), glucolipotoxicity, ER stress, oxidative stress, mitochondrial dysfunction, and islet amyloid polypeptide (IAPP) aggregation.
Is beta-cell apoptosis reversible?
Apoptosis itself is generally irreversible, but loss of beta-cell identity and dedifferentiation, which may precede apoptosis, are not always irreversible and can potentially be reversed.
What is the role of COX6A2 in beta-cell apoptosis?
COX6A2, a cytochrome c oxidase subunit regulated by FXR, triggers mitochondrial apoptosis of pancreatic beta cells in type 2 diabetes.
How does Klotho affect beta-cell apoptosis?
Klotho, an antiaging gene, attenuates pancreatic beta-cell apoptosis in type 1 diabetes, likely through inhibition of oxidative stress and NF-kB signaling.
Can CRISPR be used to study beta-cell apoptosis?
Yes, CRISPR knockout, point mutation knock-in, knock-in reporters, and overexpression models are widely used to study gene function in beta-cell apoptosis.
What is the link between IAPP and beta-cell apoptosis?
Islet amyloid polypeptide (IAPP) aggregates to form toxic oligomers that induce beta-cell apoptosis through membrane disruption and oxidative stress, contributing to type 2 diabetes.
What are the best cell models for studying beta-cell apoptosis?
Common models include INS-1 and MIN6 beta-cell lines, primary mouse or human islets, and iPSC-derived beta cells. In vivo models include beta-cell-specific knockout mice and transgenic mice expressing human IAPP.
Conclusion
GO:0097050, type B pancreatic cell apoptotic process, is a fundamental biological process that underlies beta-cell loss in diabetes mellitus. Its regulation involves a complex interplay of Bcl-2 family proteins, caspases, mitochondrial factors, inflammatory cytokines, and metabolic signals. Advances in CRISPR-based gene editing and screening technologies are accelerating the discovery of novel regulators and therapeutic targets for preserving beta-cell mass. Continued research into this process holds promise for developing disease-modifying treatments for type 1 and type 2 diabetes.
References
- 1. Inoue R et al.. 2025. Adenylosuccinate Mediates Imeglimin-Induced Proliferative and Antiapoptotic Effects in β-Cells.. Diabetes 74(9):1589-1602 PMID: 40638403
- 2. Shao L et al.. 2024. FXR-regulated COX6A2 triggers mitochondrial apoptosis of pancreatic β-cell in type 2 diabetes.. Cell Death Dis 15(12):920 PMID: 39702527
- 3. Sun Y et al.. 2018. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction.. ACS Nano 12(8):7613-7628 PMID: 30052036
- 4. Patel S et al.. 2024. Loss of β-cell identity and dedifferentiation, not an irreversible process?. Front Endocrinol (Lausanne) 15:1414447 PMID: 38915897
- 5. Santin I et al.. 2013. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis.. Diabetes Obes Metab 15 Suppl 3:71-81 PMID: 24003923
- 6. Rojas J et al.. 2018. Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy.. J Diabetes Res 2018:9601801 PMID: 29670917
- 7. Raleigh D et al.. 2017. The β-cell assassin: IAPP cytotoxicity.. J Mol Endocrinol 59(3):R121-R140 PMID: 28811318
- 8. Lin Y et al.. 2015. Antiaging Gene Klotho Attenuates Pancreatic β-Cell Apoptosis in Type 1 Diabetes.. Diabetes 64(12):4298-311 PMID: 26340932
